CYCC fundamentals
Cyclacel Pharmaceuticals, Inc. earnings per share and revenue
CYCC earnings per share for the last quarter are -0.33 USD whereas the estimation was -0.29 USD which accounts for -13.79% surprise. Company revenue for the same period amounts to 10.00 k USD despite the estimated figure of 10.00 k USD. Estimated earnings per share for the next quarter are -0.29 USD, and revenue is expected to reach 25.00 k USD. Also watch annual changes over time to get a bigger picture of CYCC earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise